CYSTIC FIBROSIS -RELATED BONE DISEASE
DOI:
https://doi.org/10.25753/BirthGrowthMJ.v22.i4.9893Keywords:
Children, cystic fibrosis related bone diseaseAbstract
Introduction: More than seven decades have passed since the first description of cystic fibrosis as a deadly childhood disease. Since then, progress has been made to extend the lives of these patients. As a consequence, children with cystic fibrosis are living into adulthood, which was once an unexpected outcome. Nevertheless, this increased survival brought new secondary complications as well as problems caused by the long -lasting medication. Cystic fibrosis -related bone disease is a recent but common complication in long -term survivors. Since its first description in 1979, a large number of papers have been published concerning the various areas of research around this secondary complication of cystic fibrosis.
Aims: This article attempts to review the literature related to several research areas around the cystic fibrosis -related bone disease summarizing the most relevant aspects of this problem.
Development: Throughout the article the authors emphasize knowledge about the epidemiology, pathophysiology and clinical aspects, and describe the most current recommendations for the diagnosis, prevention, treatment and monitoring of cystic fibrosis -related bone disease.
Conclusions: Multifactorial aetiology and interdependence and complexity of underlying pathological mechanisms stress the need and importance of monitoring patients with cystic fibrosis- -related bone disease in specialized centers that allow a multi- -and interdisciplinary integrated and differentiated follow -up.
Downloads
References
Barreto C. Fibrose quística. In: Sociedade Portuguesa de
Pneumologia, eds. Tratado de Pneumologia. 1ª ed. Lisboa:
Permanyer Portugal; 2003. p. 927 -43.
Southern KW, Munck A, Pollitt R, Travert G, Zanolla L,
Dankert -Roelse J, et al. A survey of newborn screening
for cystic fibrosis in Europe. J Cyst Fibros 2007; 6:57 -65.
doi:10.1016/j.jcf.2006.05.008
Farrell P. The prevalence of cystic fibrosis in the European
Union. J Cyst Fibros 2008; 7:450 -3. doi:10.1016/j.
jcf.2008.03.007
Cystic Fibrosis Foundation: Patient Registry 2006 Annual
Report [Internet]. [citado 2012 Jun 15]. Disponível em:
http://www.cff.org/UploadedFiles/research/ClinicalResearch/
%20Patient%20Registry%20Report.pdf
Cystic Fibrosis Foundation: Cystic Fibrosis Foundation 2010
Annual Report [Internet]. [citado 2012 Jun 15]. Disponível
em: http://www.cff.org/UploadedFiles/aboutCFFoundation/
AnnualReport/2010 -Annual -Report.pdf
Mischler EH, Chesney PJ, Chesney RW, Mazess RB. Demineralization
in cystic fibrosis detected by direct photon absorptiometry.
Am J Dis Child 1979; 133:632 -5.
Hahn TJ, Squires AE, Halstead LR, Strominger DB. Reduced
serum 25 -hydroxyvitamin D concentration and disordered
mineral metabolism in patients with cystic fibrosis. J Pediatr
; 94:38 -42. doi:10.1016/S0022 -3476(79)80346 -7
Elkin S. Arthritis, vasculitis and bone disease. In: Bush A, Alton
EWFW, Davies JC, Griesenbach U, Jaffe A, eds. Cystic
Fibrosis in the 21st Century. Progress in Respiratory Research.
Basel: Karger; 2006. Vol. 34. p. 270 -7.
Javier RM, Jacquot J. Bone disease in cystic fibrosis: What’s
new? Joint Bone Spine 2011; 78:445 -50. doi:10.1016/j.jbspin.
11.015
Sermet -Gaudelus I, Castanet M, Retsch -Bogart G, Aris RM.
Update on cystic fibrosis -related bone disease: a special
focus on children. Paediatr Respir Rev 2009; 10:134 -42.
doi:10.1016/j.prrv.2009.05.001
Sermet -Gaudelus I, Bianchi ML, Garabédian M, Aris RM,
Morton A, Hardin DS, et al. European cystic fibrosis bone
mineralisation guidelines. J Cyst Fibros 2011; 10:S16 -23.
doi:10.1016/S1569 -1993(11)60004 -0
Cystic Fibrosis Trust: Bone mineralisation in cystic fibrosis
[Internet]. [citado 2012 Jun 15]. Disponível em: http://www.
cftrust.org.uk/aboutcf/publications/consensusdoc/Bone-
-Mineral -Booklet.pdf
Aris RM, Merkel PA, Bachrach LK, Borowitz DS, Boyle
MP, Elkin SL, et al. Guide to bone health and disease in
cystic fibrosis. J Clin Endocrinol Metab 2005; 90:1888 -96.
doi:10.1210/jc.2004 -1629
Land C, Schoenau E. Fetal and postnatal bone development:
reviewing the role of mechanical stimuli and nutrition.
Best Pract Res Clin Endocrinol Metab 2008; 22:107 -18.
doi:10.1016/j.beem.2007.09.005
World Health Organization: Assessment of fracture risk and
its application to screening for postmenopausal osteoporosis:
report of WHO study group. [Internet]. [citado 2012 Jun 15].
Acessível em:http://whqlibdoc.who.int/trs/WHO_TRS_843.pdf
Reix P, Bellon G, Braillon P. Bone mineral and body composition
alterations in paediatric cystic fibrosis patients. Pediatr
Radiol 2010; 40:301 -8. doi:10.1007/s00247 -009 -1446 -8
Legroux -Gérot I, Leroy S, Prudhomme C, Perez T, Flipo
RM, Wallaert B, et al. Bone loss in adults with cystic fibrosis:
prevalence, associated factors, and usefulness of biological
markers. Joint Bone Spine 2012; 79:73 -7. doi:10.1016/j.jbspin.
05.009
Paccou J, Zeboulon N, Combescure C, Gossec L, Cortet
B. The prevalence of osteoporosis, osteopenia and fractures
among adults with cystic fibrosis: a systematic literature
review with meta -analysis. Calcif Tissue Int 2010; 86:1 -7.
doi:10.1007/s00223 -009 -9316 -9
Sermet -Gaudelus I, Souberbielle JC, Ruiz JC, Vrielynck S,
Heuillon B, Azhar I, et al. Low bone mineral density in young
children with cystic fibrosis. Am J Respir Crit Car Med 2007;
:951 -7. doi:10.1164/rccm.200606 -776OC
Caldeira RJ, Fonseca VM, Gomes Junior SC, Chaves CR.
Prevalence of bone mineral disease among adolescents with
cystic fibrosis. J Pediatr (Rio J) 2008; 84:18 -25. doi:10.2223/
JPED.1737
Gronowitz E, Garemo M, Lindblad A, Mellstrom D, Strandvik
B. Decreased bone mineral density in normal -growing
patients with cystic fibrosis. Acta Paediatr 2003; 92:688 -93.
doi:10.1111/j.1651 -2227.2003.tb00601.x
Ujhelyi R, Treszl A, Vasarhelyi B,Holics K, Tóth M, Arató
A, et al. Bone mineral density acquisition in children and
young adults with cystic fibrosis: a follow -up study. J Ped
Gastroenterol Nutr 2004; 38:401 -6. doi:10.1097/00005176-
-200404000 -00007
Bianchi ML, Romano G, Saraifoger S, Costantini D, Limonta
C, Colombo C. BMD and body composition in children and
young patients affected by cystic fibrosis. J Bone Miner Res
; 21:388 -96. doi:10.1359/JBMR.051106
Conway SP, Oldroyd B, Brownlee KG, Wolfe SP, Truscott
JG. A cross -sectional study of bone mineral density in children
and adolescents attending a Cystic Fibrosis Centre. J
Cyst Fibros 2008; 7:469 -76. doi:10.1016/j.jcf.2008.04.004
Grey V, Atkinson S, Drury D, Casey L, Ferland G, Gundberg
C, et al. Prevalence of low bone mass and deficiencies of
vitamins D and K in pediatric patients with cystic fibrosis
from 3 canadian centers. Pediatrics 2008; 122:1014 -20. doi:
1542/peds.2007 -2336
Laursen EM, Molgaard C, Michaelsen KF, Koch C, Muller J.
Bone mineral status in 134 patients with cystic fibrosis. Arch
Dis Child 1999; 81:235 -40. doi: 10.1136/adc.81.3.235
Mortensen LA, Chan GM, Alder SC, Marshall BC. Bone mineral
status in prepubertal children with cystic fibrosis. J Pediatr
; 136:648 -52. doi:10.1067/mpd.2000.104271
Sood M, Hambleton G, Super M, Fraser WD, Adams JE, Mughal
MZ. Bone status in cystic fibrosis. Arch Dis Child 2001;
:516 -20. doi:10.1136/adc.84.6.516
Hardin DS, Arumugam R, Seilheimer DK, LeBlanc A, Ellis KJ.
Normal bone mineral density in cystic fibrosis. Arch Dis Child
; 84:363 -8. doi:10.1136/adc.84.4.363
Buntain HM, Greer RM, Schluter PJ, Wong JC, Batch JA,
Potter JM, et al. Bone mineral density in australian children,
adolescents and adults with cystic fibrosis: a controlled cross
sectional study. Thorax 2004; 59:149 -55. doi:10.1136/thorax.
006726
Kelly A, Schall JI, Stallings VA, Zemel BS. Deficits in bone mineral
contents in children and adolescents with cystic fibrosis
are related to height deficits. J Clin Densitom 2008; 11:581 -9.
doi:10.1016/j.jocd.2008.07.002
Papaioannou A, Kennedy CC, Freitag A, O’Neill J, Pui M,
Ioannidis G, et al. Longitudinal analysis of vertebral fracture
and BMD in a Canadian cohort of adult cystic fibrosis patients.
BMC Musculoskelet Disord 2008; 9:125. doi:10.1186/1471-
-2474 -9 -125
Rovner AJ, Zemel BS, Leonard MB, Schall JI, Stallings VA.
Mild to moderate cystic fibrosis is not associated with increased
fracture risk in children and adolescents. J Pediatr 2005;
:327 -31. doi:10.1016/j.jpeds.2005.04.015
Buntain HM, Schluter PJ, Bell SC, Greer RM, Wong JC, Batch
J, et al. Controlled longitudinal study of bone mass accrual
in children and adolescents with cystic fibrosis. Thorax
; 61:146 -54. doi:10.1136/thx.2005.046516
Jacquot J, Tabary O, Clement A. Hyperinflammation in airways
of cystic fibrosis patients: what’s new? Expert Rev Mol
Diagn 2008; 8:359 -63. doi:10.1586/14737159.8.4.359
Haworth CS, Selby PL, Webb AK, Martin L, Elborn JS, Sharples
LD, et al. Inflammatory related changes in bone mineral
content in adults with cystic fibrosis. Thorax 2004; 59:613 -7.
doi:10.1136/thx.2003.012047
Shead EF, Haworth CS, Barker H, Bilton D, Compston JE.
Osteoclast function, bone turnover and inflammatory cytokines
during infective exacerbations of cystic fibrosis. J Cyst
Fibros 2010; 9:93 -8. doi:10.1016/j.jcf.2009.11.007
Ionescu AA, Evans WD, Pettit RJ, Nixon LS, Stone MD, Shale
DJ. Hidden depletion of fat -free mass and bone mineral
density in adults with cystic fibrosis. Chest 2003; 124:2220 -8.
doi:10.1378/chest.124.6.2220
Kawai M, Rosen CJ. Insulin -like growth factor -I and bone: lessons
from mice and men. Pediatr Nephrol. 2009; 24:1277 -85.
doi:10.1007/s00467 -008 -1040 -6
Hillman LS, Cassidy JT, Popescu MF, Hewett JE, Kyger J,
Robertson JD. Percent true calcium absorption, mineral metabolism,
and bone mineralization in children with cystic fibrosis:
effect of supplementation with vitamin D and calcium.
Pediatr Pulmonol 2008; 43:772 -80. doi:10.1002/art.23809
Schulze KJ, O’Brien KO, Germain -Lee EL, Baer D, Leonard
ALR, Rosenstein BR. Endogenous fecal losses of calcium
compromise calcium balance in pancreatic -insufficient girls
with cystic fibrosis. J Pediatr 2003; 143:765 -71. doi:10.1067/
S0022 -3476(03)00539 -0
Schulze KJ, Cutchins C, Rosenstein BJ,Germain -Lee EL,
O’BrienKO. Calcium acquisition rates do not support age-
-appropriate gains in total body mineral content in prepuberty
and late puberty in girls with cystic fibrosis. Osteoporos Int
; 17:731 -40. doi:10.1007/s00198 -005 -0041 -6
Borowitz D, Baker RD, Stallings V. Consensus report on
nutrition for pediatric patients with cystic fibrosis. J Pediatr
Gastroenterol Nutr 2002; 35:246 -59. doi:10.1097/01.
MPG.0000025580.85615.14
Hall WB, Sparks AA, Aris RM. Vitamin D deficiency
in cystic fibrosis. Int J Endocrinol 2010; 2010:218691.
doi:10.1155/2010/218691
Fewtrell MS, Benden C, Williams JE,Chomtho S, Ginty F,
Nigdikar SV,et al. Undercarboxylated osteocalcin and bone
mass in 8 -12 year old children with cystic fibrosis. J Cyst Fibr
; 7:307 -12. doi:10.1016/j.jcf.2007.11.006
Conway SP, Wolfe SP, Brownlee KG, White H, Oldroyd B,
Truscott JG,et al. Vitamin K status among children with cystic
fibrosis and its relationship to bone mineral density and
bone turnover. Pediatrics 2005; 115:1325 -31. doi:10.1542/
peds.2004 -1242
Dodd JD, Barry SC, Barry RB, Cawood TJ, McKenna MJ,
Gallagher CG. Bone mineral density in cystic fibrosis: benefit
of exercise capacity. J Clin Densitom 2008; 11:537 -42.
doi:10.1016/j.jocd.2008.05.095
Arrigo T, De Luca F, Lucanto C, Lombardo M, Rulli I, Salzano
G, et al. Nutritional, glycometabolic and genetic factors affecting
menarcheal age in cystic fibrosis. Diabetes Nutr Metab
; 17:114 -9.
Jin R, Hodges CA, Drumm ML, Palmert MR. The Cystic fibrosis
transmembrane conductance regulator (CFTR) modulates
the timing of puberty in mice. J Med Genet 2006; 43:e29.
doi:10.1136/jmg.2005.032839
Shead EF, Haworth CS, Condliffe AM, McKeon DJ, Scott MA,
Compston JE. Cystic fibrosis transmembrane conductance
regulator (CFTR) is expressed in human bone. Thorax 2007;
:650 -1. doi:10.1136/thx.2006.075887
Aris RM, Ontjes DA, Buell HE, Blackwood AD, Lark RK, Caminiti
M, et al. Abnormal bone turnover in cystic fibrosis adults.
Osteoporos Int 2002; 13:151 -7. doi:10.1007/s001980200007
Schoenau E, Land C, Stabrey A, Remer T, Kroke A. The
bone mass concept: problems in short stature. Eur J Endocrinol
; 151:S87 -91. doi:10.1530/eje.0.151S087
Fewtrell MS,British Paediatric & Adolescent Bone Group.
Bone densitometry in children assessed by dual X ray absorptiometry:
uses and pitfalls.Arch Dis Child 2003; 88:795 -8.
doi:10.1136/adc.88.9.795
American Academy of Pediatrics. Bone Densitometry in
Children and Adolescents. Pediatrics 2011; 127:189 -94.
doi:10.1542/peds.2010 -2961
National Osteoporosis Society: A practical guide to bone densitometry
in children[Internet]. [citado 2012 Jun 30]. Disponível
em: http://www.nos.org.uk/document.doc?id=851
Nicolaidou P, Stavrinadis I, Loukou I, Papadopoulou A, Georgouli
H, Douros K, et al. The effect of vitamin K supplementation
on biochemical markers of bone formation in children and
adolescents with cystic fibrosis. Eur J Pediatr 2006; 165:540-
-5. doi:10.1007/s00431 -006 -0132 -1
Hind K, Truscott JG, Conway SP. Exercise during childhood
and adolescence: A prophylaxis against cystic fibrosis-
-related low bone mineral density? Exercise for bone health
in children with cystic fibrosis. J Cyst Fibros 2008; 7:270 -6.
doi:10.1016/j.jcf.2008.02.001
Phillipi CA, Remmington T, Steiner RD. Bisphosphonate therapy
for osteogenesis imperfecta. Cochrane Database Syst
Rev 2008; 4:CD005088. doi:10.1002/14651858.CD005088.
pub2.
Conwell LS, Chang AB. Bisphosphonates for osteoporosis
in people with cystic fibrosis. Cochrane Database Syst Rev
; 4:CD002010. doi:10.1002/14651858.CD002010.pub3.
Phung OJ, Coleman CI, Baker EL, Scholle JM, Girotto JE,
Makanji SS, et al. Recombinant human growth hormone in
the treatment of patients with cystic fibrosis. Pediatrics 2010;
:e1211 -26. doi:10.1542/peds.2010 -2007
Downloads
Published
How to Cite
Issue
Section
License
Copyright and Authors' Rights
All articles published in Nascer e Crescer - Birth and Growth Medical Journal are Open Access and comply with the requirements of funding agencies or academic institutions. For use by third parties, Nascer e Crescer - Birth and Growth Medical Journal adheres to the terms of the Creative Commons License "Attribution - Non-Commercial Use (CC-BY-NC)".
It is the author's responsibility to obtain permission to reproduce figures, tables, etc. from other publications.
Authors must submit a Conflict of Interest statement and an Authorship Form with the submission of the article. An e-mail will be sent to the corresponding author confirming receipt of the manuscript.
Authors are permitted to make their articles available in repositories at their home institutions, provided that they always indicate where the articles were published and adhere to the terms of the Creative Commons license.
